Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-10 Sale |
2025-03-12 2:24 pm |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D & CMO |
2,403 | $138.41 | $332,605 | 79,621 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 6:49 pm |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D & CMO |
12,319 | $138.75 | $1,709,257 | 82,024 (Direct) |
View |
| 2023-06-05 Sale |
2023-06-07 7:16 pm |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of Research a |
1,311 | $129.73 | $170,076 | 45,315 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 5:16 pm |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D |
1,844 | $151.54 | $279,440 | 36,316 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-27 Option Award |
2025-03-03 8:22 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, G R&D and CMO |
26,577 | $0 | 94,343 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 6:58 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, G R&D and CMO |
7,506 | $0 | 67,766 (Direct) |
View |
| 2025-01-17 Tax Withholding |
2025-01-22 6:58 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, G R&D and CMO |
2,181 | $122.62 | 67,766 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 8:00 pm |
2025-06-11 2034-06-11 |
iTeos Therapeutics Inc. | ITOS | Iannone Robert Director |
24,200 | $0 | 24,200 (Direct) |
View |
| 2024-03-05 Tax Withholding |
2024-03-07 9:47 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D |
4,294 | $117.53 | 62,226 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:47 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D |
16,928 | $0 | 66,520 (Direct) |
View |
| 2024-01-17 Option Award |
2024-01-19 6:25 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D |
5,970 | $0 | 49,592 (Direct) |
View |
| 2024-01-17 Tax Withholding |
2024-01-19 6:25 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D |
1,730 | $119.13 | 49,592 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 7:55 pm |
2024-06-13 2033-06-13 |
iTeos Therapeutics Inc. | ITOS | Iannone Robert Director |
22,383 | $0 | 22,383 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 9:22 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of Research a |
12,447 | $0 | 46,489 (Direct) |
View |
| 2023-03-05 Tax Withholding |
2023-03-07 9:22 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of Research a |
2,274 | $142.78 | 46,489 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:05 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Iannone Robert Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 7:53 pm |
N/A 2032-06-09 |
iTeos Therapeutics Inc. | ITOS | Iannone Robert Director |
17,538 | $0 | 17,538 (Direct) |
View |
| 2022-06-06 Tax Withholding |
2022-06-08 5:01 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D |
1,295 | $149.25 | 38,109 (Direct) |
View |
| 2022-03-05 Tax Withholding |
2022-03-09 5:54 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D and Ch |
1,327 | $153.96 | 39,257 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-09 5:54 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D and Ch |
11,374 | $0 | 39,257 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:47 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Iannone Robert Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 8:24 pm |
N/A 2031-06-17 |
iTeos Therapeutics Inc. | ITOS | Iannone Robert Director |
4,560 | $0 | 4,560 (Direct) |
View |
| 2021-06-05 Tax Withholding |
2021-06-09 6:57 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP R&D, Chief Medical Officer |
1,206 | $176.47 | 29,086 (Direct) |
View |
| 2021-04-29 Option Award |
2021-05-03 7:09 pm |
N/A 2031-04-29 |
iTeos Therapeutics Inc. | ITOS | Iannone Robert Director |
33,217 | $0 | 0 (Direct) |
View |
| 2021-03-05 Tax Withholding |
2021-03-09 7:30 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP R&D, Chief Medical Officer |
741 | $164.75 | 30,145 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 5:55 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Research & Development |
8,535 | $0 | 30,886 (Direct) |
View |
| 2020-06-26 Option Award(A) |
2020-07-02 7:35 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | Iannone Robert Director |
7,850 | $0 | 7,850 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-29 7:32 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | Iannone Robert Director |
6,775 | $0 | 6,775 (Direct) |
View |
| 2020-06-05 Tax Withholding |
2020-06-05 9:38 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Research & Development |
943 | $120.65 | 22,204 (Direct) |
View |